Barriers to clinical trials. Part I: Reimbursement problems.

@article{Fleming1994BarriersTC,
  title={Barriers to clinical trials. Part I: Reimbursement problems.},
  author={Irvin D Fleming},
  journal={Cancer},
  year={1994},
  volume={74 9 Suppl},
  pages={2662-5}
}
Most of the major clinical advancement in cancer treatment has been provided by cancer clinical trials. Approximately 60% of clinical trials are conducted in the community treatment setting and approximately 40% in academic and cancer centers. The cost of these trials are borne by a combination of third-party reimbursement for the cancer care and institution and research study support for the specific cost of the research trial. With the increasing emphasis on cost control, managed cancer care… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…